Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,955 | -27,749 | -88,441 | -55,059 | -54,046 |
| Depreciation Amortization | 1,351 | 699 | 2,415 | 1,745 | 1,146 |
| Accounts receivable | -8,016 | -2,479 | 102 | -19,793 | 252 |
| Other Working Capital | -9,783 | -4,179 | 5,263 | -17,420 | 675 |
| Other Operating Activity | 18,375 | 8,183 | 20,574 | 31,685 | 7,247 |
| Operating Cash Flow | $-30,028 | $-25,525 | $-60,087 | $-58,842 | $-44,726 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 63,151 | 33,474 | -4,782 | 48,760 | 34,327 |
| PPE Investments | -43 | -43 | 31 | 70 | 70 |
| Investing Cash Flow | $63,108 | $33,431 | $-4,751 | $48,830 | $34,397 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 185 | 3 | 46,608 | 1,320 | 981 |
| Financing Cash Flow | $185 | $3 | $46,608 | $1,320 | $981 |
| Beginning Cash Position | 13,861 | 13,861 | 32,091 | 32,091 | 32,091 |
| End Cash Position | 47,126 | 21,770 | 13,861 | 23,399 | 22,743 |
| Net Cash Flow | $33,265 | $7,909 | $-18,230 | $-8,692 | $-9,348 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,028 | -25,525 | -60,087 | -58,842 | -44,726 |
| Capital Expenditure | -43 | -43 | -39 | N/A | N/A |
| Free Cash Flow | -30,071 | -25,568 | -60,126 | -58,842 | -44,726 |